📰 Technology Limited News
Page 29 - Technology Limited News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Technology Limited. Real-time updates on events, politics, business and more.
October 17, 2022
Arigna filed a patent infringement action against various vehicle manufacturers that alleged infringement of U.S. Patent No. 7,397,318 ("‘318 Patent"). The ‘318 Patent is direct toward a voltage control oscillator...
October 13, 2022
VGI Health Technology Limited (NSX:VTL) is pleased to announce that it has entered into an R&D Loan Facility Agreement (Loan Facility) with Fundsquire Pty Ltd.
October 12, 2022
Ugochukwu Obiora Chime, GMD & CEO Copen Group Award Winning Company Breaking Records in Real Estate He has well over 40 years of dynamic and wide industry experience cutting across the civil service, public service and the private sectors of the Nigerian economy. Mr. Ugochukwu Obiora Chime is the Group Managing Director/CEO of Copen Group, […]
October 12, 2022
A Qualitative Research Study accomplished by Data Bridge Market researchs database of 350 pages, titled “Pharmaceutical Packaging Equipment Market” with 100+
October 12, 2022
OTAQ Plc (OTAQ) Proposed Placing and Open Offer, Delisting & AQSE Admission, Capital Reorganisation and Board Appointments 12-Oct-2...
October 12, 2022
/PRNewswire/ -- The global breast pump market is expected to reach USD 5.20 billion by 2030, according to a new report by Grand View Research, Inc. The market...
October 5, 2022
VGI Health Technology Limited (NSX:VTL) is an Australian public listed biotechnology company developing and commercialising novel dietary supplements and prescription medicines based on natural products (tocotrienols) which have wide therapeutic potential, including: Delayed Onset Muscle Soreness, muscle recovery, exercise endurance, Non-Alcoholic Fatty Liver Disease (NAFLD), Non-Alcoholic SteatoHepatitis (NASH), pancreatic cancer, hyperlipidaemia, hypertension and diabetes. VTL owns and control...
October 5, 2022
VGI Health Technology Limited (NSX:VTL) is pleased to announce that its wholly owned subsidiary, Invictus Ops Pty Ltd (Invictus), has commenced dosing of patients for its Phase II clinical study in Non-Alcoholic Fatty Liver Disease.
September 30, 2022
/PRNewswire/ -- Recent study report released by Data Bridge Market research titled Global Traction Motor Market (covering USA, Europe, China, Japan, India,...
September 30, 2022
SEOUL, South Korea, Sept. 30, 2022 /PRNewswire/ -- Recent study report released by Data Bridge Market research titled 'Global Traction Motor Market' (covering USA, Europe, China, Japan, India